1-18 of 18
Keyword: cardiovascular riskClose
Clin Sci (Lond) (2019) 133 (21): 2221–2235.
Published: 13 November 2019
...-I cardiovascular risk high-density lipoprotein metabolic disorders Cardiovascular disease (CVD) is the leading cause of death worldwide and accounted for 32% of global mortality in 2013 [ 1 ]. Death from CVD is higher in people with metabolic disorders, such as Type 2 diabetes (T2D) and...
Stella Bernardi, Rebecca Voltan, Erika Rimondi, Elisabetta Melloni, Daniela Milani, Carlo Cervellati, Donato Gemmati, Claudio Celeghini, Paola Secchiero, Giorgio Zauli, Veronica Tisato
Clin Sci (Lond) (2019) 133 (10): 1145–1166.
Published: 16 May 2019
... bind and internalize TWEAK is also shown. FADD is Fas-associated DD. TRAF is TNF receptor-associated factor. The figure legend shows a schematic representation of all ligands and receptors. biomarkers cardiovascular risk diabetic kidney disease non-diabetic kidney disease TRAIL and OPG...
Andreia Z. Chignalia, Maria Aparecida Oliveira, Victor Debbas, Randal O. Dull, Francisco R.M. Laurindo, Rhian M. Touyz, Maria Helena C. Carvalho, Zuleica B. Fortes, Rita C. Tostes
Clin Sci (Lond) (2015) 129 (1): 39–48.
Published: 01 April 2015
...Andreia Z. Chignalia; Maria Aparecida Oliveira; Victor Debbas; Randal O. Dull; Francisco R.M. Laurindo; Rhian M. Touyz; Maria Helena C. Carvalho; Zuleica B. Fortes; Rita C. Tostes The mechanisms whereby testosterone increases cardiovascular risk are not clarified. However, oxidative stress and...
Includes: Supplementary data
Juan Marcelo Fernández, Daniel Rosado-Álvarez, Marzo Edir Da Silva Grigoletto, Oriol Alberto Rangel-Zúñiga, Leslie Lorena Landaeta-Díaz, Javier Caballero-Villarraso, José López-Miranda, Francisco Pérez-Jiménez, Francisco Fuentes-Jiménez
Clin Sci (Lond) (2012) 123 (6): 361–373.
Published: 29 May 2012
... cardiovascular risk endothelial progenitor cell Mediterranean diet microvascular reactivity moderate-to-high-intensity training The MetS (metabolic syndrome) increases the risk of cardiovascular morbidity and mortality [ 1 ]. Recently, this phenomenon has been linked to EPCs (endothelial progenitors...
Clin Sci (Lond) (2011) 120 (4): 153–160.
Published: 02 November 2010
... a cohort of young adults (mean age 22 years) and their siblings participating in a longitudinal study of cardiovascular risk ( n =370). Insulin sensitivity was determined by euglycaemic insulin clamp. EDD (endothelium-dependent dilation) was determined by flow-mediated dilation using high-resolution...
Clin Sci (Lond) (2010) 118 (10): 607–615.
Published: 23 February 2010
...: Professor Gerald F. Watts (email firstname.lastname@example.org ). 5 11 2009 14 12 2009 5 1 2010 5 1 2010 © The Authors Journal compilation © 2010 Biochemical Society 2010 cardiovascular risk dyslipidaemia endothelial dysfunction fenofibrate statin Type 2 diabetes In...
Clin Sci (Lond) (2009) 116 (4): 273–282.
Published: 15 January 2009
... syndromes and other vascular complications. The principal goal of the present review is to evaluate the role of central BP measurements, principally systolic and pulse pressure, for cardiovascular risk assessment. Recent findings suggest that the pulsatile component of BP (when represented by central pulse...
Wibke Reinhard, Klaus Stark, Kamil Sedlacek, Marcus Fischer, Andrea Baessler, Katharina Neureuther, Stefan Weber, Bernhard Kaess, Silke Wiedmann, Stefan Mitsching, Wolfgang Lieb, Jeanette Erdmann, Christa Meisinger, Angela Doering, Ralf Tolle, Andreas Jeron, Guenter Riegger, Christian Hengstenberg
Clin Sci (Lond) (2008) 115 (10): 301–308.
Published: 15 October 2008
... Society 2008 cardiovascular risk case-control study gene polymorphism myocardial infarction peroxisome-proliferator-activated receptor α (PPARα) MI (myocardial infarction) is considered a complex disease. Its development and progression underlies interactions between environmental and...
Clin Sci (Lond) (2008) 114 (8): 561–566.
Published: 13 March 2008
...Vance A. Spence; Gwen Kennedy; Jill J. F. Belch; Alexander Hill; Faisel Khan Some of the symptoms reported by people with CFS (chronic fatigue syndrome) are associated with various cardiovascular phenomena. Markers of cardiovascular risk, including inflammation and oxidative stress, have been...
Brian A. Haluska, Leanne Jeffriess, Joseph Brown, Melodie Downey, Stephane G. Carlier, Thomas H. Marwick
Clin Sci (Lond) (2008) 114 (6): 441–447.
Published: 12 February 2008
... assessing arterial elasticity using the DC (distensibility coefficient) measured by TDI, the correlation of this with the DC obtained by other methods and the DC in patients with various degrees of cardiovascular risk. We studied 450 subjects (256 men; age, 51±10 years) with and without risk factors of...
Piyush M. Srivastava, Paul Calafiore, Richard J. Macisaac, Sheila K. Patel, Merlin C. Thomas, George Jerums, Louise M. Burrell
Clin Sci (Lond) (2008) 114 (4): 313–320.
Published: 15 January 2008
... were rigorously assessed by comprehensive transthoracic echocardiographic techniques in 229 patients with Type 2 diabetes. Cardiovascular risk factors and diabetic complications were assessed, and predictors of an abnormal echocardiogram were identified using multivariate logistic regression analysis...
Marileia Scartezini, Christina Hubbart, Ros A. Whittall, Jackie A. Cooper, Andrew H. W. Neil, Steve E. Humphries
Clin Sci (Lond) (2007) 113 (11): 435–441.
Published: 01 November 2007
... Biochemical Society 2007 apolipoprotein B (ApoB) coronary heart disease cardiovascular risk familial hypercholesterolaemia low-density lipoprotein cholesterol (LDL-C) protein convertase subtilisin/kexin type 9 gene ( PCSK9 ) total cholesterol The PCSK9 (protein convertase subtilisin...
Annette Maznyczka, Massimo Mangino, Andrew Whittaker, Peter Braund, Tom Palmer, Martin Tobin, Alison H. Goodall, Peter Bradding, Nilesh J. Samani
Clin Sci (Lond) (2007) 112 (7): 411–416.
Published: 01 March 2007
... difference in the mean level for LTB 4 production in the three groups (non-A/non-B, 24.9±8.3 ng/10 6 cells; HapA, 22.2±11.9 ng/10 6 cells; HapB, 19.8±4.8 ng/10 6 ; P =0.14). The findings indicate that if either the HapA or the HapB haplotype of ALOX5AP indeed increases cardiovascular risk, then the mechanism...
Clin Sci (Lond) (2006) 111 (5): 341–347.
Published: 13 October 2006
... Libby (email email@example.com ). 23 2 2006 2 6 2006 19 7 2006 19 7 2006 The Biochemical Society 2006 assay interference cardiovascular risk CD40 ligand (CD40L) cytokine soluble CD40L The soluble form of the inflammatory and pro-atherogenic...
Clin Sci (Lond) (2004) 106 (2): 121–128.
Published: 01 February 2004
... distribution of C-reactive protein (CRP) and other markers of inflammation and their relationships with cardiovascular risk markers and renal disease in a remote Australian Aboriginal community. The study included 237 adults (58% of the adult population) in a remote Aboriginal community in the Northern...
Clin Sci (Lond) (1994) 87 (2): 201–206.
Published: 01 August 1994
... © 1994 The Biochemical Society and the Medical Research Society 1994 body composition body fat cardiovascular risk growth hormone deficiency insulin muscle mass obesity Clinical Science (1994) 87, 201-206 (Printed in Great Britain) 20 I Interactions of body fat and muscle mass with...
Clin Sci (Lond) (1993) 85 (2): 219–222.
Published: 01 August 1993
... patients. 26 3 1993 15 4 1993 © 1993 The Biochemical Society and the Medical Research Society 1993 acute-phase proteins cardiovascular risk hypertriglyceridaemia sialic acid Clinical Science (1993) 85, 219-222 (Printed in Great Britain) Serum sialic acid and acute-phase...
Clin Sci (Lond) (1992) 83 (5): 593–595.
Published: 01 November 1992
...M. Crook; P. Tutt 1. Serum total sialic acid concentration, recently shown to be a cardiovascular risk factor, and also serum lipid-associated sialic acid concentration were measured in 15 patients with hypertriglyceridaemia (fasting serum triacylglycerol concentration > 2.3 mmol/l) showing a...